All News Eton Pharmaceuticals, Inc.

Equities

ETON

US29772L1089

Delayed Nasdaq Other stock markets 12:55:31 2024-05-09 pm EDT			5-day change	1st Jan Change
3.7 ^USD	-0.54%		-1.33%	-15.53%

Apr. 30	Sector Update: Health Care Stocks Gain in Afternoon Trading	MT
Apr. 30	Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference	May. 01	GL
Sector Update: Health Care Stocks Gain in Afternoon Trading	Apr. 30	MT
Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400	Apr. 30	MT
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)	Apr. 30	GL
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)	Apr. 30	AQ
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)	Apr. 30	CI
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024	Apr. 29	GL
Eton Pharmaceuticals, Inc. cancelled the transaction announced on April 15, 2024	Apr. 16	CI
Eton Pharmaceuticals, Inc. announced that it expects to receive $13.125 million in funding	Apr. 14	CI
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE	Mar. 25	AQ
Sector Update: Health Care Stocks Steady Pre-Bell Friday	Mar. 22	MT
Sector Update: Health Care	Mar. 22	MT
Eton Pharmaceuticals Acquires U.S. Rights to PKU GOLIKE from Relief Therapeutics Holding SA	Mar. 22	CI
Eton Pharmaceuticals Acquires US Rights to Phenylketonuria Dietary Management Product	Mar. 22	MT
Relief Therapeutics Grants Eton Pharmaceuticals Exclusive License for US Commercialization of Golike	Mar. 22	MT
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	Mar. 22	AQ
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	Mar. 22	GL
Transcript : Eton Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 14, 2024	Mar. 14
Eton Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
Earnings Flash (ETON) ETON PHARMACEUTICALS Posts Q4 Revenue $7.3M, vs. Street Est of $7.66M	Mar. 14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Eton Pharmaceuticals, Inc.

Equities

ETON

US29772L1089

All News

Filters